Distinct Autoantibody Profiles in Systemic Lupus Erythematosus Patients Are Selectively Associated with TLR7 and TLR9 Upregulation

Overview

Journal J Clin Immunol

Publisher Springer

Specialty Allergy & Immunology

Date 2013 Apr 9

PMID 23564191

Citations 48

Authors

Sudhir Kumar Chauhan

Vikas Vikram Singh

Richa Rai

Madhukar Rai

Geeta Rai

Affiliations

Soon will be listed here.

Abstract

Purpose: Systemic lupus erythematosus (SLE) patients have a wide array of autoantibodies against nuclear antigens. The two predominant classes of these autoantibodies are directed either against dsDNA or RNA-associated antigens (extractable nuclear antigens; ENA). Nucleic-acid sensing Toll-like receptors (TLRs) that recognize dsDNA and RNA, have been well implicated in some murine models of SLE. We took up this study to identify if unique TLR expression patterns are associated with distinct autoantibody profiles in SLE.

Methods: We segregated the patients into three subsets distinguished on the basis of autoantibody response either against dsDNA or ENA or both. We determined the mRNA expression of TLR3, 7, 8, and 9 by real-time reverse-transcription PCR in peripheral blood leucocytes (PBLs) of the SLE patients of all three subsets. TLR7 and 9 protein expression was determined by western blotting in PBLs and by flow cytometry on B-cells and monocytes. The serum interferon-alpha (IFN-α) and anti-dsDNA/-ENA autoantibodies were detected using enzyme-linked immunosorbant assay.

Results: We report differential and unique TLR expression patterns associated with different autoantibody profiles. The presence of anti-ENA and anti-dsDNA autoantibodies in SLE patients was associated with elevated levels of TLR7 and TLR9 respectively. The TLR9 mRNA expression was further augmented in SLE patients with Glomerulonephritis. Interestingly, anti-dsDNA(+) ENA(+) patients displayed higher serum IFN-α and interferon regulatory factor 7 mRNA expression than patients with either anti-dsDNA or anti-ENA autoantibodies alone.

Conclusion: Characteristic TLRs expression profile associated with distinct autoantibody repertoire is suggestive of differential immuno-regulatory pathways operative in different subsets of SLE patients.

Citing Articles

Heightened TLR7 signaling primes BCR-activated B cells in chronic graft-versus-host disease for effector functions.

Bracken S, Suthers A, DiCioccio R, Su H, Anand S, Poe J Blood Adv. 2023; 8(3):667-680.

PMID: 38113462 PMC: 10839617. DOI: 10.1182/bloodadvances.2023010362.

Intravenous Administration of Toll-Like Receptor Inhibitory Peptide 1 is Effective for the Treatment of Systemic Lupus Erythematosus in a Model.

Baek W, Lee S, Lee S, Son I, Choi S, Suh C J Rheum Dis. 2023; 28(3):133-142.

PMID: 37475994 PMC: 10324895. DOI: 10.4078/jrd.2021.28.3.133.

Pathogenic cellular and molecular mediators in lupus nephritis.

Mohan C, Zhang T, Putterman C Nat Rev Nephrol. 2023; 19(8):491-508.

PMID: 37225921 DOI: 10.1038/s41581-023-00722-z.

A Study on MDA5 Signaling in Splenic B Cells from an Imiquimod-Induced Lupus Mouse Model with Proteomics.

Su Y, Li F, Sheu J, Li S, Weng S, Shen F Cells. 2022; 11(21).

PMID: 36359746 PMC: 9657434. DOI: 10.3390/cells11213350.

COVID-19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severity.

Jiang W, Johnson D, Adekunle R, Heather H, Xu W, Cong X J Med Virol. 2022; 95(1):e28134.

PMID: 36086941 PMC: 9538121. DOI: 10.1002/jmv.28134.

References

Mosca M, Chimenti D, Pratesi F, Baldini C, Anzilotti C, Bombardieri S . Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J Rheumatol. 2006; 33(4):695-7. View

Papadimitraki E, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I . Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheum. 2006; 54(11):3601-11. DOI: 10.1002/art.22197. View

Jongbloed S, Kassianos A, McDonald K, Clark G, Ju X, Angel C . Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens. J Exp Med. 2010; 207(6):1247-60. PMC: 2882828. DOI: 10.1084/jem.20092140. View

Sanchez-Guerrero J, Lew R, Fossel A, Schur P . Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus. Arthritis Rheum. 1996; 39(6):1055-61. DOI: 10.1002/art.1780390626. View

Linnik M, Hu J, Heilbrunn K, Strand V, Hurley F, Joh T . Relationship between anti-double-stranded DNA antibodies and exacerbation of renal disease in patients with systemic lupus erythematosus. Arthritis Rheum. 2005; 52(4):1129-37. DOI: 10.1002/art.20980. View

Hochberg M . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9):1725. DOI: 10.1002/art.1780400928. View

Nakano S, Morimoto S, Suzuki J, Nozawa K, Amano H, Tokano Y . Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Rheumatology (Oxford). 2007; 47(2):145-9. DOI: 10.1093/rheumatology/kem327. View

Gladman D, Ibanez D, Urowitz M . Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002; 29(2):288-91. View

Rai G, Ray S, Milton J, Yang J, Ren P, Lempicki R . Gene expression profiles in a rabbit model of systemic lupus erythematosus autoantibody production. J Immunol. 2010; 185(7):4446-56. PMC: 2949067. DOI: 10.4049/jimmunol.1001254. View

10.

Grammer A, Lipsky P . B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther. 2004; 5 Suppl 4:S22-7. PMC: 2833441. DOI: 10.1186/ar1009. View

11.

Zhang R, Xing M, Ji X, Gu L, Yang X, Wang H . Interferon-alpha and interleukin-6 in SLE serum induce the differentiation and maturation of dendritic cells derived from CD34+ hematopoietic precursor cells. Cytokine. 2010; 50(2):195-203. DOI: 10.1016/j.cyto.2010.02.017. View

12.

Subramanian S, Tus K, Li Q, Wang A, Tian X, Zhou J . A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A. 2006; 103(26):9970-5. PMC: 1502563. DOI: 10.1073/pnas.0603912103. View

13.

Baechler E, Batliwalla F, Karypis G, Gaffney P, Ortmann W, Espe K . Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A. 2003; 100(5):2610-5. PMC: 151388. DOI: 10.1073/pnas.0337679100. View

14.

Migita K, Miyashita T, Maeda Y, Nakamura M, Yatsuhashi H, Kimura H . Toll-like receptor expression in lupus peripheral blood mononuclear cells. J Rheumatol. 2007; 34(3):493-500. View

15.

Takeuchi O, Akira S . Pattern recognition receptors and inflammation. Cell. 2010; 140(6):805-20. DOI: 10.1016/j.cell.2010.01.022. View

16.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

17.

Akira S, Takeda K, Kaisho T . Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001; 2(8):675-80. DOI: 10.1038/90609. View

18.

Niewold T, Hua J, Lehman T, Harley J, Crow M . High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun. 2007; 8(6):492-502. PMC: 2702174. DOI: 10.1038/sj.gene.6364408. View

19.

Pisitkun P, Deane J, Difilippantonio M, Tarasenko T, Satterthwaite A, Bolland S . Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006; 312(5780):1669-72. DOI: 10.1126/science.1124978. View

20.

Kim T, Kanayama Y, Negoro N, Okamura M, Takeda T, Inoue T . Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol. 1987; 70(3):562-9. PMC: 1542177. View